Alpha Cognition Inc. (ACOG)

Nasdaq Biotechnology Diagnostics SIC: 2836
A
Pipeline Grade

Financial Position (from SEC Filings)

$54.3M
Cash & Equivalents
$11.8M
Quarterly Burn Rate
14 mo
Est. Cash Runway
$125M
Market Cap

Estimated from most recent SEC quarterly filing. View SEC filings

Drug Pipeline (1 Assets)

DrugPhaseIndications
BENZGALANTAMINE GLUCONATE
ZUNVEYL 		APPROVED —

Upcoming Catalysts

No upcoming catalysts detected for this company.

More Analysis

AI Stock Score

SEC EDGAR fundamental analysis with Claude AI & ChatGPT ratings for ACOG.

SEC EDGAR Filings

All SEC filings for Alpha Cognition Inc. on EDGAR.

Full Calendar

View all upcoming FDA catalysts across all biotech companies.